kabutan

SAWAI GROUP HOLDINGS Co.,Ltd.(4887) Summary

4887
TSE Prime
SAWAI GROUP HOLDINGS Co.,Ltd.
2,086.5
JPY
-12.0
(-0.57%)
Apr 30, 10:52 am JST
13.02
USD
Apr 29, 9:52 pm EDT
Result
PTS
outside of trading hours
2,087.6
Apr 30, 10:51 am JST
Summary Chart Historical News Financial Result
PER
17.2
PBR
1.35
Yield
2.64%
Margin Trading Ratio
1.39
Stock Price
Apr 30, 2026
Opening Apr 30, 9:00 am
2,105.5 JPY 13.14 USD
Previous Close Apr 28
2,098.5 JPY 13.18 USD
High Apr 30, 9:02 am
2,110.5 JPY 13.17 USD
Low Apr 30, 9:39 am
2,083.0 JPY 13.00 USD
Volume
106,900
Trading Value
0.22B JPY 1.40M USD
VWAP
2097.07 JPY 13.09 USD
Minimum Trading Value
208,650 JPY 1,302 USD
Market Cap
0.24T JPY 1.51B USD
Number of Trades
502
Liquidity & Number of Trades
As of Apr 30, 2026
Liquidity
High
1-Year Average
1,388
1-Year High May 15, 2025
5,000
Margin Trading
Date Short Interest Long Margin Positions Ratio
Apr 24, 2026 198,400 24,100 0.12
Apr 17, 2026 189,500 20,200 0.11
Apr 10, 2026 176,000 18,400 0.10
Apr 3, 2026 169,900 17,900 0.11
Mar 27, 2026 184,000 29,600 0.16
Company Profile
SAWAI GROUP HOLDINGS Co., Ltd. is a leading generic pharmaceutical company, specializing in lifestyle disease treatments and anti-cancer drugs. The company is focusing on expanding its business in the United States.
Sector
Pharmaceuticals
SAWAI GROUP HOLDINGS Co., Ltd. primarily engages in the manufacturing and sales of prescription and over-the-counter pharmaceuticals. The group consists of a holding company and eight consolidated subsidiaries, operating under a single segment of "manufacturing and sales of pharmaceuticals and related products." The core company, Sawai Pharmaceutical Co., Ltd., manufactures and sells pharmaceuticals to domestic distributors, wholesalers, other pharmaceutical manufacturers, and medical institutions. Medisa Shinyaku Co., Ltd. handles the sales of prescription drugs, while Kaken Shoyaku Co., Ltd. is responsible for the manufacturing and sales of prescription drugs and the supply of primary raw materials. Trust Pharmatech Co., Ltd. manufactures and sells prescription drugs and is entrusted with part of the research and development and manufacturing operations from Sawai Pharmaceutical. The group as a whole strives for efficient business operations and aims to strengthen its competitiveness in the pharmaceutical market.